COM:GINKGOBIOWORKS
Ginkgo Bioworks
- Stock
Last Close
6.59
22/11 21:00
Market Cap
725.64M
Beta: -
Volume Today
129
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | -119.86M - | -126.72M 5.73% | -1.84B 1,349.34% | -2.11B 14.69% | -892.87M 57.61% | |
depreciation and amortization | 10.76M - | 13.86M 28.91% | 29.08M 109.72% | 44.42M 52.78% | 71.55M 61.07% | |
deferred income tax | 54.73M - | 4.13M 92.46% | 30.21M 631.70% | -14.61M 148.35% | -801K 94.52% | |
stock based compensation | 771K - | 476K 38.26% | 1.61B 337,299.16% | 1.93B 20.21% | 229.88M 88.09% | |
change in working capital | 10.58M - | -26.52M 350.69% | -61.54M 132.08% | -37.01M 39.86% | 29.84M 180.63% | |
accounts receivables | -1.84M - | -14.23M 672.00% | -114.09M 701.90% | 55.02M 148.23% | 50.07M 9.01% | |
inventory | -2.22M - | -2.74M 23.13% | -626K 77.12% | 164K 126.20% | ||
accounts payables | 664K - | 7.02M 957.08% | -2.25M 132.01% | -10.84M 382.60% | -1.18M 89.09% | |
other working capital | 13.98M - | -16.57M 218.54% | 55.43M 434.52% | -81.35M 246.76% | -19.05M 76.59% | |
other non cash items | -1.64M - | -1.06M 35.38% | -20.95M 1,874.27% | -69.28M 230.72% | 266.89M 485.27% | |
net cash provided by operating activities | -44.66M - | -135.83M 204.12% | -253.82M 86.86% | -252.20M 0.64% | -295.50M 17.17% | |
investments in property plant and equipment | -22.22M - | -57.82M 160.23% | -56.52M 2.25% | -52.27M 7.52% | -40.80M 21.94% | |
acquisitions net | -12.04M - | 26.65M 321.31% | -38.55M 244.68% | |||
purchases of investments | -50.13M - | -5M - | -3.69M 26.18% | |||
sales maturities of investments | ||||||
other investing activites | -2.25M - | -9.30M 313.33% | 304K 103.27% | -38.08M 12,625.66% | -1.34M 96.48% | |
net cash used for investing activites | -74.60M - | -67.12M 10.03% | -73.26M 9.14% | -67.39M 8.00% | -80.69M 19.73% | |
debt repayment | -828K - | -748K 9.66% | -1.12M 50.13% | -1.24M 10.15% | -1.29M 4.69% | |
common stock issued | 91.07M - | 1.51B 1,557.91% | 99.30M 93.42% | -487K 100.49% | ||
common stock repurchased | -408K - | -25.00M - | -981K 96.08% | |||
dividends paid | -1.51B - | -981K 99.94% | ||||
other financing activites | 411.62M - | 90.32M 78.06% | 1.56B 1,627.52% | -767K 100.05% | -1.43M 86.96% | |
net cash used provided by financing activities | 410.38M - | 90.32M 77.99% | 1.53B 1,598.60% | 95.34M 93.79% | -3.22M 103.37% | |
effect of forex changes on cash | -19K - | 908K 4,878.95% | -588K 164.76% | |||
net change in cash | 291.12M - | -112.63M 138.69% | 1.21B 1,171.67% | -223.35M 118.50% | -375.15M 67.97% | |
cash at beginning of period | 207.39M - | 498.51M 140.37% | 385.88M 22.59% | 1.59B 312.81% | 1.32B 16.88% | |
cash at end of period | 498.51M - | 385.88M 22.59% | 1.59B 312.81% | 1.37B 14.02% | 948.86M 30.72% | |
operating cash flow | -44.66M - | -135.83M 204.12% | -253.82M 86.86% | -252.20M 0.64% | -295.50M 17.17% | |
capital expenditure | -22.22M - | -57.82M 160.23% | -56.52M 2.25% | -52.27M 7.52% | -40.80M 21.94% | |
free cash flow | -66.88M - | -193.65M 189.54% | -310.34M 60.26% | -304.47M 1.89% | -336.30M 10.45% |
All numbers in USD (except ratios and percentages)